Subsequently, the downstream signal transduction pathways were activated and large amounts of inflammatory mediators were released, such as TNF-α (Figures 4B–D), which cross the blood-brain barrier (BBB) to induce dysregulation of neurotransmitters and promote depression-like behaviors (47–49). This evidence concerns the gene TNF and depressive symptom measurement.